Los Angeles, California (FSCwire) - PTS, Inc. (the "Company" or “PTS") (OTC Pink: PTSH) announced today that it closed on its bridge  loan to Mariposa Health Limited (“Mariposa Health”), a pharmaceutical product development company specializing in the fields of lung conditions and inflammatory conditions that is based in Australia. Under the terms of the agreement PTS granted a term loan of US $500,000 so the company could carry through on a reverse merger and capital funding required for advancement of its COPD products. As part of the loan agreement, PTS will receive an equity interest of 4% in Mariposa Health.

"We are pleased we could accommodate Mariposa in it financial structuring and needs," stated Lowell Holden, President and CEO of PTS. "Our ongoing equity interest in Mariposa will definitely benefit our Company over the long term.

“This financing provided by PTS allows us to move forward with our US $45 million capital raise to complete our phase 2 clinical trial of our Chronic Obstructive Pulmonary Disease (COPD) and asthma treatment products,” states Dr. Phillip Comans, Executive Chairman and CEO of Mariposa Health.

About PTS: PTS, Inc. is a company which invests in various businesses which allows the Company to maintain a long term relationship and equity interest. The administrative office is in Los Angeles, CA.

About Mariposa Health Ltd:  Mariposa Health is a pharmaceutical R&D Australian Company with 2 products TA-270 and HI-164OV which have completed their phase one and seven phase 2 clinical trials. The results to date have shown significant benefits to those suffering from COPD.  Mariposa Health products are cover by 8 significant patents.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as PTS, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report for the most recent fiscal year.

Contact:

Lowell Holden

Email:  ltholden@comcast.net

Telephone: (612) 961-5656

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2015 Filing Services Canada Inc.